[Ip-health] The 2016 Tufts estimates of the risk adjusted out-of-pocket costs to develop a new drug. | Knowledge Ecology International

Jamie Love james.love at keionline.org
Tue Apr 12 23:26:25 PDT 2016


​I wrote a note which explains some of the issues in the way that the 2016
Tufts/DiMasi report estimates the out-of-pocket and risk adjusted costs of
drug development.

Joe can point out anything he things is wrong here, and I'll fix it if


More information about the Ip-health mailing list